Introduction
The simultaneous or sequential occurrence of infection with 2 or more pathogens is well recognized,' although how such mixed infections influence clinical presentation and outcome remains poorly understood. Both Mycoplasma pneumoniae and Legionella pneumophila are important causes of pneumonia in man, and there are many reports of co-infection between these and other pathogens.2`A high degree of serological co-positivity between M. pneumonia and L. pneumophila has also been reported in the United States,5-8 although these findings have not been confirmed in this country, using an indirect fluorescent antibody test and a more specific formalin inactivated yolk sac antigen for the detection of L. pneumophila.9-" It has been suggested that this observed co-positivity may be due to serological cross-reactivity through the use of relatively non-specific preparations of legionella antigen, or may reflect true geographical differences in the patterns of infection with these organisms between the 2 countries. Overall, the consensus to date has been that true dual infection with these pathogens is rare. There is only one previous report of definite dual infection in the literature, and in this case the diagnosis of legionella infection was established by direct immunofluorescence and not serologically. 6 We report a further case of probable co-infection with M. pneumoniae and L. pneumophila, diagnosed using the more specific techniques employed in the UK.
Case report
A previously healthy 19 year old male was admitted to St George's Hospital, London in a deep coma. During the week prior to admission he had developed a sore throat and productive cough, and had become increasingly apathetic and drowsy. On examination, the patient was comatose with a temperature of 39.5°C, blood pressure of 150/90 mmHg and a pulse rate of 130/min. There was evidence of meningism but no focal neurological signs. Physical examination was otherwise normal. Initial investigations showed an elevated white blood cell count of 17 x 109/l (81% neutrophils), but electrolytes and liver function tests were normal. Chest X-ray revealed patchy infiltrates at the left lung base. Arterial blood gases on air were: P02 5 kPa, PCO2 4 16 (or a single titre of > 32).12 Legionella infection in this case was inferred from the presence of a significant titre rise in both tests and in both laboratories during the 4th week of admission and from a CSF titre of 16. Serum aliquots were also analysed by the Legionella Reference Laboratory, which found non-diagnostic titres. However, on review it was apparent that the vials had been repeatedly frozen and thawed, and not vortexed prior to dispatch to the Reference Laboratory. In view of this sampling error, these results were omitted from the table.
Routine
Over the course of the next 6 weeks there was a slow improvement in his neurological state. By the 8th day he was alert and orientated, and able to blink in response to commands; by the 14th day he could lateralize his gaze to command and after a month, some movement of his mouth and tongue appeared. Six weeks following admission, a magnetic resonance imaging scan demonstrated the presence of multifocal cortical (mainly white matter) disease. An EEG was within normal limits and an electromyelogram showed severe widespread denervation in all limbs, compatible with anterior horn cell and motor root involvement, with preserved sensory action potentials.
There has been no further evidence of neurological recovery: he remains quadriplegic, able to move his eyes, and to mouth words but not to speak or swallow.
Discussion
The difficulties in establishing a serological diagnosis of infection are well recognized. Serology is an indirect method of detecting the presence of an infectious agent, with relatively poor sensitivity and specificity. Furthermore, in the absence of international gold standards, the serological techniques may vary, resulting in considerable problems of quality control. However, at least for the serodiagnosis of M. pneumoniae, 3 L. pneumophila'2 and Epstein-Barr virus'4 infections, there are well-established guidelines. Our patient fulfilled the necessary serological criteria for recent infection with all 3 agents. The diagnosis of mycoplasma infection was suggested by 3 laboratories, each using different techniques and L. pneumophila antibody was detected by 2 laboratories. The discrepant findings of the Legionella Reference Laboratory were attributed to a sampling error, as discussed above. There are several possible interpretations of these findings. Firstly, both L. pneumophila and M. pneumoniae may have cross-reacted with a single antibody in the patient's serum, generating a false positive reaction. This phenomenon probably accounts for the majority of cases of co-infection reported previously,5`8 because of the use of a cross-reactive heat or ether-killed L. pneumophila antigen grown on solid media.9-" However, the use, as in this case, of a formalin-killed yolk sac legionella antigen has largely overcome this problem. Subsequent studies have shown that crossreactions are uncommon using this antigen.9-1" Another interpretation is that the rise in antibody titres was spurious, due to non-specific polyclonal B cell activation. Biberfeld and others have demonstrated that M. pneumoniae is a B-lymphocyte activator capable of inducing non-specific activation of memory B cells in vivo."5-"' Such an anamnestic response to M. pneumoniae has been reported with EBV and one possible case with legionella infection. '8 Thirdly and more likely is that true co-infection with M. pneumoniae and L. pneumophila occurred, followed by an EBV infection. It is difficult to establish the precise timing of exposure to the two agents, since the incubation period and mean interval to seroconversion vary widely for both infections. Seroconversion to legionella, for example, often occurs several weeks after the onset of the disease.'9 There was an early peak during the second week in mycoplasma IgG and IgM antibody titres, and the IgM titres remained elevated into the fourth week, which was also the time of the rise in antibody titres to L. pneumophila. M. pneumoniae is also known to suppress cellular immunity,'7 and immunocompromised patients are predisposed to legionella infection. This, together with the serology, suggest that M. pneumoniae was the primary pathogen with a secondary L. pneumophila infection. The timing of the rise in EBV antibody titres, shortly after the massive blood transfusion and the subsequent rise in IgG and anti-EBNA noted 9 weeks later, is strongly suggestive of a transfusion-acquired infection. An alternative explanation is that this was simply a reactivation of a latent EBV infection by M. pneumoniae. However, this interpretation is precluded by the initial negative anti-EBNA titre, which would be expected to remain positive indefinitely following a primary infection. '4 The overall clinical presentation and course provide no additional insight as to the likely contribution and time relationship of the two infections. L. pneumophila infection resembles M. pneumoniae, particularly with respect to clinical manifestations and neurological complications.2022 However, it is possible that the subsequent febrile illness associated with liver dysfunction, initially assumed to be part of a drug reaction, was in fact a manifestation of L. pneumophila infection or possibly even early EBV infection. The absence of a history of recent travel, time spent in an airconditioned building, legionella antibodies in the sera of other patients on the intensive care unit, or of any other recent local cases of Legionnaire's disease, suggest that this was probably a sporadic case of L. pneumophila.
The pathogenesis of the CNS disease with M. pneumoniae is unknown. Four hypotheses have been proposed and include direct invasion of the central nervous system by the organism, production of a neurotoxin, autoimmune mechanisms, or vascular damage.22 Confirmatory isolation of the organism in the CSF was not possible in this case. However, the presence of M. pneumoniae IgM and CF antibody in the CSF lends some support to the hypothesis of direct central nervous system invasion, although this may simply reflect passage of serum titres across a damaged blood-brain barrier. L. pneumophila is also a recognized infectious cause of neurological damage. While it is impossible to delineate the precise contribution of either agent to the clinical picture, it is conceivable that the two organisms acted synergistically in the pathogenesis of the neurological disease, as has been postulated with cytomegalovirus and the human immunodeficiency virus (HIV). 23 This case serves to highlight some of the problems in the serological diagnosis of legionella and mycoplasma infections. In recent years, improved culture techniques and diagnostic methods of antigen detection, such as indirect immunofluorescence with monoclonal antibodies and enzyme linked immunoassay,24 have been developed. In addition, cDNA probes25 and the polymerase chain reaction have been used to detect mycoplasma ribosomal RNA and DNA, respectively. Although these techniques are currently available in only a few specialized laboratories, they offer the potential for the future to characterize more precisely the epidemiology of mycoplasma and legionella infection and further cases of dual infection. Finally, it would seem appropriate in cases of acute meningoencephalitis or related central nervous system pathology where no cause has been established, to search also for evidence ofboth M. pneumoniae and L. pneumophila infection even in the absence of pneumonia, and to consider the early empirical use of intravenous erythromycin.
